Biosafety Testing: The Journey from Starting Materials through Unprocessed Bulk Testing to Viral Clearance

Biosafety is a critical aspect of biopharmaceutical manufacturing, ensuring both product quality and safety. Every stage—from starting materials to unprocessed bulk testing and viral clearance—plays a vital role in maintaining product integrity. However, challenges such as cost, time constraints, and potential pitfalls can impact project success. This infographic traverses the biosafety testing journey - from cell bank testing to stability testing and storage - and offers key points to consider, key testing challenges, and strategic considerations to streamline each step of the biosafety testing journey.

 A Look at Now, Next, and Future in Developing Pharmaceuticals

Download Now

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.